Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 7;3(2):e00108.
doi: 10.1002/edm2.108. eCollection 2020 Apr.

The impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitus

Anand Thakarakkattil Narayanan Nair  1 , Louise A Donnelly  1 , Adem Y Dawed  1 , Sushrima Gan  1 , Ranjit M Anjana  2 , Mohan Viswanathan  2 , Colin N A Palmer  1 , Ewan R Pearson  1
Affiliations
Review

The impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitus

Anand Thakarakkattil Narayanan Nair et al. Endocrinol Diabetes Metab. .

Abstract

Aim: To conduct a comprehensive review of studies of glycaemic deterioration in type 2 diabetes and identify the major factors influencing progression.

Methods: We conducted a systematic literature search with terms linked to type 2 diabetes progression. All the included studies were summarized based upon the factors associated with diabetes progression and how the diabetes progression was defined.

Results: Our search yielded 2785 articles; based on title, abstract and full-text review, we included 61 studies in the review. We identified seven criteria for diabetes progression: 'Initiation of insulin', 'Initiation of oral antidiabetic drug', 'treatment intensification', 'antidiabetic therapy failure', 'glycaemic deterioration', 'decline in beta-cell function' and 'change in insulin dose'. The determinants of diabetes progression were grouped into phenotypic, ethnicity and genotypic factors. Younger age, poorer glycaemia and higher body mass index at diabetes diagnosis were the main phenotypic factors associated with rapid progression. The effect of genotypic factors on progression was assessed using polygenic risk scores (PRS); a PRS constructed from the genetic variants linked to insulin resistance was associated with rapid glycaemic deterioration. The evidence of impact of ethnicity on progression was inconclusive due to the small number of multi-ethnic studies.

Conclusion: We have identified the major determinants of diabetes progression-younger age, higher BMI, higher HbA1c and genetic insulin resistance. The impact of ethnicity is uncertain; there is a clear need for more large-scale studies of diabetes progression in different ethnic groups.

Keywords: diabetes progression; glycaemic deterioration; insulin initiation; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Figure 1
Figure 1
Flow diagram of Literature reduction process
Figure 2
Figure 2
Major factors at diagnosis influencing diabetes progression (factors reported by at least two studies)
See this image and copyright information in PMC

References

    1. Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care. 2009;32(suppl_2):S151‐S156 - PMC - PubMed
    1. Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25(3):476‐481. - PubMed
    1. Li R, Bilik D, Brown MB, et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care. 2013;19(5):421‐430. - PMC - PubMed
    1. GBD 2015 DALYs and HALE Collaborators NJ , Arora M, Barber RM, et al. Global, regional, and national disability‐adjusted life‐years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (London, England). 2016;388(10053):1603‐1658. - PMC - PubMed
    1. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes‐related cardiovascular comorbidities in the U.S., 2000–2002. Diabetes Care. 2005;28(7):1599‐1603. - PubMed